ADVAXIS
Advaxis is a clinical-stage biotechnology company developing the next generation of immunotherapies for cancer and infectious diseases. Advaxis immunotherapies are based on a novel platform technology using live, attenuated bacteria that are bio-engineered to secrete antigen/adjuvant fusion protein(s) designed to redirect the powerful immune response all human beings have to the bacterium to the cancer itself. ADXS-HPV is being evaluated in four clinical trials for HPV-associated diseases: re... current/refractory cervical cancer (India), locally advanced cervical cancer (GOG/NCI US study), head and neck cancer (CRUK study), and anal cancer (BrUOG). Over fifteen (15) distinct constructs are in various stages of development, developed directly by the Company and through strategic collaborations with recognized centers of excellence.
ADVAXIS
Industry:
Biotechnology Health Diagnostics Pharmaceutical
Founded:
2002-01-01
Address:
Princeton, New Jersey, United States
Country:
United States
Website Url:
http://www.advaxis.com
Total Employee:
51+
Status:
Active
Contact:
609-452-9813
Email Addresses:
[email protected]
Total Funding:
156.18 M USD
Technology used in webpage:
Domain Not Resolving Mobile Non Scaleable Content IPv6 Sectigo SSL Sectigo Domain SSL Comcast OneTrust Optanon Internet Names For Business AppDynamics
Similar Organizations
Acreage Holdings
Acreage Holdings is a vertically integrated, multi-state owner of cannabis licenses and assets in states.
Clear Labs
Clear Labs is a provider of a fully-automated sequencing platform for turnkey diagnostics.
Diaceutics
Diaceutics Group leverages analytics, software, services and consulting.
NanoString Technologies
NanoString Technologies provides a life science tools platform for a variety of basic research, translational medicine and IVD applications.
NeoGenomics
NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.
OPKO Health
Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics.
Quanterix
Quanterix is a biotechnology company that develops ultrasensitive biomarker detection for healthcare.
Schrödinger
Schrödinger develops molecular design software for pharma/biotech and materials research, and is advancing a drug discovery pipeline.
Trinity Biotech
Trinity Biotech has actively pursued the aim of becoming a leading player in the international diagnostics.
Vetcove
Vetcove is the largest B2B veterinary marketplace, enabling veterinary hospitals to compare and buy supplies from all of their vendors.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Cantor Fitzgerald
Cantor Fitzgerald investment in Post-IPO Equity - Advaxis
Jefferies
Jefferies investment in Post-IPO Equity - Advaxis
Guggenheim Securities
Guggenheim Securities investment in Post-IPO Equity - Advaxis
Knight Therapeutics
Knight Therapeutics investment in Post-IPO Equity - Advaxis
Sectoral Asset Management
Sectoral Asset Management investment in Post-IPO Equity - Advaxis
Cormorant Asset Management
Cormorant Asset Management investment in Post-IPO Equity - Advaxis
Adage Capital Management
Adage Capital Management investment in Post-IPO Equity - Advaxis
T. Rowe Price
T. Rowe Price investment in Post-IPO Equity - Advaxis
Broadfin Capital
Broadfin Capital investment in Post-IPO Equity - Advaxis
Sectoral Asset Management
Sectoral Asset Management investment in Post-IPO Equity - Advaxis
More informations about "Advaxis"
Advaxis - Crunchbase Company Profile & Funding
Advaxis is a clinical-stage biotechnology company developing the next generation of immunotherapies for cancer and infectious diseases. Advaxis immunotherapies are based on a novel platform technology using live, attenuated bacteria that …See details»
Advaxis, Ayala Pharmaceuticals Complete Merger - PharmTech
On Jan. 19, 2023, Advaxis, Inc., a biotechnology company focused on the discovery, development, and commercialization of immunotherapies, completed a previously announced …See details»
Advaxis - Wikiwand
Advaxis Inc. is an American company devoted to the discovery, development and commercialization of immunotherapies based on a technology platform which uses engineered …See details»
Advaxis Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 Advaxis (NASDAQ: ADXS) is a clinical-stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune …See details»
Advaxis - Org Chart, Teams, Culture & Jobs - The Org
View Advaxis' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. This is an unverified company page.See details»
Advaxis and Ayala Pharmaceuticals Complete Merger - Nasdaq
Jan 19, 2023 --Advaxis, Inc., a biotechnology company devoted to the discovery, development and commercialization of immunotherapies based on a technology which uses engineered …See details»
Morgan Lewis Advising Advaxis Inc. in Ayala Pharmaceuticals Merger
Oct 19, 2022 Advaxis is a biotechnology company devoted to the discovery, development, and commercialization of immunotherapies based on a technology which uses engineered Listeria …See details»
Advaxis Announces Receipt of Funding Milestone Payment Under …
Jan 19, 2021 About Advaxis, Inc. Advaxis, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of proprietary Lm-based antigen delivery …See details»
Advaxis, Inc. Issues Letter to Stockholders - Nasdaq
Nov 16, 2021 --Advaxis, Inc., a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, today issued the following …See details»
Advaxis and Merck Announce Initiation of Enrollment in the Phase …
Apr 8, 2015 KEYNOTE-046 is the second trial initiated to evaluate KEYTRUDA, and the first-in-human study of ADXS-PSA, for prostate cancer Advaxis, Inc. (NASDAQ:ADXS), a clinical …See details»
OTC Markets Group Welcomes Advaxis, Inc. to OTCQX - PR …
Dec 23, 2021 Advaxis, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of proprietary Lm-based antigen delivery products. These …See details»
Advaxis Submits Special Protocol Assessment Request to FDA for …
Jun 15, 2015 About Advaxis, Inc. Located in Princeton, N.J. , Advaxis, Inc. is a clinical-stage biotechnology company developing multiple cancer immunotherapies based on its proprietary …See details»
Advaxis, Inc. Announces $20 Million Registered Direct Offering
Apr 12, 2021 --Advaxis, Inc., a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, today announced it has …See details»
Advaxis doses first patient in Phase l trial of ADXS-NEO
Advaxis has dosed the first patient in a Phase l trial of ADXS-NEO for the treatment of metastatic non-small cell lung cancer (NSCLC), metastatic microsatellite stable colon cancer and …See details»
Working at Advaxis: 7 Reviews - Indeed
Reviews from Advaxis employees about Advaxis culture, salaries, benefits, work-life balance, management, job security, and more. Home. Company reviews. Find salaries. Sign in. Sign in. …See details»
Advaxis therapy improves survival rates in cervical cancer patients
Sep 17, 2015 Advaxis Inc said its experimental cancer vaccine was found more effective in improving survival rates of cervical cancer patients than standard therapy, validating the …See details»
Advaxis Updates on the Phase 1 Clinical Trial of ADXS-504 for
Jan 12, 2023 Advaxis, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of proprietary Lm-based antigen delivery products.See details»
Advaxis to Present Updated Clinical and Immunogenicity Data
May 26, 2022 About Advaxis, Inc. Advaxis, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of proprietary Lm-based antigen delivery …See details»
Advaxis Announces Updated Survival Data in Phase 1/2 ADXS-PSA …
Feb 13, 2020 About Advaxis, Inc. Advaxis, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of proprietary Lm-based antigen delivery …See details»